Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | APLT |
---|---|---|
09:32 ET | 14545 | 8.07 |
09:34 ET | 1650 | 7.9779 |
09:36 ET | 7006 | 8 |
09:38 ET | 2589 | 8.01 |
09:39 ET | 4528 | 7.98 |
09:41 ET | 3079 | 7.99 |
09:43 ET | 951 | 7.94 |
09:45 ET | 1824 | 7.9562 |
09:48 ET | 1880 | 7.975 |
09:50 ET | 3346 | 7.935 |
09:52 ET | 1229 | 7.88 |
09:54 ET | 100 | 7.895 |
09:56 ET | 2078 | 7.8872 |
09:57 ET | 8578 | 7.865 |
09:59 ET | 100 | 7.85 |
10:01 ET | 700 | 7.84 |
10:03 ET | 3515 | 7.81 |
10:06 ET | 1956 | 7.855 |
10:08 ET | 600 | 7.87 |
10:10 ET | 1612 | 7.825 |
10:12 ET | 300 | 7.8 |
10:14 ET | 1120 | 7.835 |
10:15 ET | 300 | 7.89 |
10:17 ET | 6756 | 7.9298 |
10:19 ET | 900 | 7.92 |
10:21 ET | 1854 | 7.92 |
10:24 ET | 1358 | 7.8601 |
10:26 ET | 4630 | 7.88 |
10:28 ET | 1306 | 7.895 |
10:30 ET | 200 | 7.888 |
10:32 ET | 9255 | 7.8324 |
10:33 ET | 13574 | 7.85 |
10:35 ET | 4486 | 7.81 |
10:37 ET | 9975 | 7.85 |
10:39 ET | 4505 | 7.82 |
10:42 ET | 2294 | 7.83 |
10:44 ET | 2000 | 7.8 |
10:46 ET | 1810 | 7.82 |
10:48 ET | 1790 | 7.83 |
10:50 ET | 2490 | 7.85 |
10:51 ET | 5139 | 7.83 |
10:53 ET | 1028 | 7.84 |
10:55 ET | 1133 | 7.84 |
10:57 ET | 601 | 7.85 |
11:00 ET | 5370 | 7.83 |
11:02 ET | 1091 | 7.86 |
11:04 ET | 1200 | 7.86 |
11:06 ET | 2909 | 7.845 |
11:08 ET | 1700 | 7.845 |
11:09 ET | 412 | 7.84 |
11:11 ET | 200 | 7.835 |
11:13 ET | 1735 | 7.84 |
11:15 ET | 418 | 7.825 |
11:18 ET | 900 | 7.8107 |
11:20 ET | 200 | 7.82 |
11:22 ET | 7479 | 7.78 |
11:24 ET | 849 | 7.77 |
11:26 ET | 1836 | 7.79 |
11:27 ET | 119 | 7.791 |
11:29 ET | 100 | 7.7911 |
11:31 ET | 1520 | 7.78 |
11:33 ET | 2967 | 7.79 |
11:36 ET | 3283 | 7.8 |
11:38 ET | 1003 | 7.81 |
11:40 ET | 1125 | 7.8 |
11:42 ET | 3400 | 7.8 |
11:44 ET | 1700 | 7.8 |
11:45 ET | 4448 | 7.8 |
11:47 ET | 1507 | 7.81 |
11:49 ET | 500 | 7.83 |
11:51 ET | 100 | 7.83 |
11:54 ET | 500 | 7.82 |
11:56 ET | 2454 | 7.834 |
11:58 ET | 712 | 7.835 |
12:00 ET | 756 | 7.83 |
12:02 ET | 500 | 7.855 |
12:07 ET | 1168 | 7.87 |
12:09 ET | 200 | 7.88 |
12:12 ET | 1900 | 7.895 |
12:14 ET | 100 | 7.89 |
12:16 ET | 9378 | 7.85 |
12:18 ET | 10378 | 7.85 |
12:20 ET | 300 | 7.85 |
12:21 ET | 700 | 7.85 |
12:23 ET | 2424 | 7.85 |
12:25 ET | 1688 | 7.8 |
12:27 ET | 1100 | 7.81 |
12:30 ET | 725 | 7.835 |
12:32 ET | 100 | 7.835 |
12:34 ET | 1500 | 7.79 |
12:36 ET | 300 | 7.8 |
12:38 ET | 300 | 7.79 |
12:39 ET | 915 | 7.8 |
12:41 ET | 2278 | 7.77 |
12:48 ET | 2454 | 7.79 |
12:50 ET | 100 | 7.79 |
12:54 ET | 5682 | 7.77 |
12:56 ET | 1318 | 7.7701 |
12:57 ET | 500 | 7.8 |
12:59 ET | 1003 | 7.7969 |
01:01 ET | 400 | 7.8 |
01:03 ET | 1100 | 7.7925 |
01:06 ET | 3099 | 7.81 |
01:08 ET | 1672 | 7.78 |
01:10 ET | 6861 | 7.8 |
01:12 ET | 568 | 7.8 |
01:14 ET | 4379 | 7.83 |
01:15 ET | 100 | 7.83 |
01:19 ET | 2063 | 7.81 |
01:21 ET | 772 | 7.8 |
01:24 ET | 200 | 7.81 |
01:26 ET | 100 | 7.81 |
01:30 ET | 6644 | 7.8 |
01:32 ET | 700 | 7.8 |
01:33 ET | 300 | 7.8 |
01:35 ET | 387 | 7.79 |
01:37 ET | 100 | 7.8 |
01:39 ET | 960 | 7.78 |
01:42 ET | 300 | 7.785 |
01:44 ET | 3500 | 7.79 |
01:50 ET | 1600 | 7.78 |
01:51 ET | 2688 | 7.75 |
01:53 ET | 100 | 7.7614 |
01:55 ET | 1368 | 7.76 |
01:57 ET | 100 | 7.76 |
02:02 ET | 900 | 7.75 |
02:04 ET | 1144 | 7.76 |
02:06 ET | 385 | 7.76 |
02:08 ET | 1574 | 7.755 |
02:11 ET | 1170 | 7.77 |
02:15 ET | 2100 | 7.75 |
02:18 ET | 3624 | 7.75 |
02:20 ET | 200 | 7.76 |
02:22 ET | 666 | 7.77 |
02:24 ET | 200 | 7.77 |
02:26 ET | 829 | 7.78 |
02:27 ET | 100 | 7.785 |
02:29 ET | 100 | 7.78 |
02:36 ET | 3812 | 7.77 |
02:38 ET | 400 | 7.77 |
02:40 ET | 927 | 7.76 |
02:42 ET | 300 | 7.765 |
02:45 ET | 100 | 7.76 |
02:49 ET | 600 | 7.7623 |
02:51 ET | 123 | 7.7712 |
02:54 ET | 600 | 7.79 |
02:56 ET | 100 | 7.782 |
03:00 ET | 300 | 7.8 |
03:02 ET | 2669 | 7.805 |
03:03 ET | 2082 | 7.78 |
03:05 ET | 1786 | 7.77 |
03:07 ET | 947 | 7.8 |
03:09 ET | 200 | 7.8 |
03:12 ET | 300 | 7.79 |
03:14 ET | 2043 | 7.78 |
03:16 ET | 100 | 7.78 |
03:18 ET | 1329 | 7.795 |
03:20 ET | 6779 | 7.7775 |
03:23 ET | 1754 | 7.79 |
03:25 ET | 866 | 7.78 |
03:27 ET | 11298 | 7.74 |
03:30 ET | 12503 | 7.75 |
03:32 ET | 400 | 7.73 |
03:34 ET | 1069 | 7.75 |
03:36 ET | 16115 | 7.71 |
03:38 ET | 3212 | 7.68 |
03:39 ET | 10440 | 7.68 |
03:41 ET | 15893 | 7.6475 |
03:43 ET | 12427 | 7.62 |
03:45 ET | 40771 | 7.6 |
03:48 ET | 28521 | 7.64 |
03:50 ET | 28122 | 7.6 |
03:52 ET | 2213 | 7.63 |
03:54 ET | 19455 | 7.61 |
03:56 ET | 10251 | 7.64 |
03:57 ET | 11187 | 7.65 |
03:59 ET | 263959 | 7.7 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Applied Therapeutics Inc | 884.3M | -5.1x | --- |
Mereo BioPharma Group PLC | 677.0M | -13.5x | --- |
Perspective Therapeutics Inc | 900.2M | -9.6x | --- |
Oruka Therapeutics Inc | 891.4M | -4.3x | --- |
IGM Biosciences Inc | 914.1M | -4.2x | --- |
Arrivent Biopharma Inc | 915.6M | -11.1x | --- |
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of central nervous system (CNS) rare metabolic diseases, including Galactosemia, Sorbitol Dehydrogenase (SORD) Deficiency, and PMM2-CDG. The Company is also developing AT-001, a novel potent ARI, for the treatment of Diabetic Cardiomyopathy (DbCM) a fatal fibrosis of the heart. It has completed a Phase I/II clinical trial evaluating AT-001 in approximately 120 patients with type 2 diabetes, in which no drug-related adverse effects or tolerability issues were observed. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of Diabetic retinopathy.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $884.3M |
---|---|
Revenue (TTM) | $-333.0K |
Shares Outstanding | 114.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.03 |
EPS | $-1.52 |
Book Value | $-0.20 |
P/E Ratio | -5.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.